Announcement • Mar 17
Merlin Labs, Inc completed the acquisition of Inflection Point Acquisition Corp. IV (NasdaqGM : BACQ) from group of shareholders in a reverse merger transaction. Merlin Labs, Inc executed letter of intent to acquire Inflection Point Acquisition Corp. IV (NasdaqGM : BACQ) from group of shareholders in a reverse merger transaction on June 10, 2025. Merlin Labs, Inc. entered into a definitive business combination agreement to acquire Bleichroeder Acquisition Corp. I from group of shareholders in a reverse merger transaction for $800 million on August 13, 2025. Prior to or concurrent with the Domestication, the Company shall file a certificate of amendment to the certificate of incorporation of the Company with the Secretary of State of Delaware changing the Company’s corporate name to “Merlin Labs Operations, Inc.” or another name mutually agreed on by the Purchaser and the Company prior to the Domestication. The business combination is expected to deliver gross proceeds of at least $128 million from the committed PIPE, with up to $257 million additional proceeds depending on redemptions. These proceeds will be used to accelerate Merlin’s technology development, expand the delivery of its capabilities to customers, enable strategic acquisitions, and ensure top talent across areas including avionics and machine learning continue joining Merlin.
Bleichroeder Acquisition Corp. I changed its name to Inflection Point Acquisition Corp. IV in October 2025. The Boards of Directors of both Merlin and Bleichroeder have unanimously approved the proposed transaction. The deal is subject to customary closing conditions, including approval by Bleichroeder shareholders and regulatory review. The deal is expected to close in early 2026. In connection with the closing of the transaction, Inflection Point Acquisition Corp. IV will change its name to Merlin, Inc.
Joel L. Rubinstein and Matthew Kautz of White & Case LLP and Ellenoff Grossman & Schole LLP act as legal advisor, Cantor Fitzgerald & Co. and Cohen & Company act as financial advisor for Bleichroeder Acquisition Corp. I, Inflection Point agreed to pay to CCM an aggregate cash amount of $8,750,000 as “deferred underwriting commissions”. Stephen W. Ranere and Nick Dhesi of Latham & Watkins LLP as legal advisor,TD Securities (USA) LLC act as financial advisor for Merlin Labs, Inc. Greenberg Traurig is serving as legal advisor to TD Cowen. Continental Stock Transfer & Trust Company acted as transfer agent to Inflection Point Acquisition Corp. IV. Newbridge Securities Corporation acted as financial advisor, fairness opinion provider to Inflection Point Acquisition Corp. IV, will receive a fee of $0.055 million for opinion rendered and $0.02 million for services. Alliance Advisors LLC acted as a Proxy solicitor to Inflection Point Acquisition and Inflection Point has agreed to pay Alliance Advisors a fee of $22,500, plus disbursements. The Depository Trust Company acted as a depository bank to Inflection Point Acquisition.
Merlin Labs, Inc completed the acquisition of Inflection Point Acquisition Corp. IV (NasdaqGM : BACQ) from group of shareholders in a reverse merger transaction on March 16, 2026. On March 17, 2026, the combined company will begin trading on NASDAQ under the ticker symbol “MRLN.” Announcement • Aug 15
Merlin Labs, Inc. entered into a definitive business combination agreement to acquire Bleichroeder Acquisition Corp. I (NasdaqGM:BACQ) from Inflection Point Fund I, LP and Bleichroeder Sponsor 1 LLC for $800 million in a reverse merger transaction. Merlin Labs, Inc. entered into a definitive business combination agreement to acquire Bleichroeder Acquisition Corp. I (NasdaqGM:BACQ) from Inflection Point Fund I, LP and Bleichroeder Sponsor 1 LLC for $800 million in a reverse merger transaction on August 13, 2025. Prior to or concurrent with the Domestication, the Company shall file a certificate of amendment to the certificate of incorporation of the Company with the Secretary of State of Delaware changing the Company’s corporate name to “Merlin Labs Operations, Inc.” or another name mutually agreed on by the Purchaser and the Company prior to the Domestication. The business combination is expected to deliver gross proceeds of at least $128 million from the committed PIPE, with up to $257 million additional proceeds depending on redemptions. These proceeds will be used to accelerate Merlin’s technology development, expand the delivery of its capabilities to customers, enable strategic acquisitions, and ensure top talent across areas including avionics and machine learning continue joining Merlin. The Boards of Directors of both Merlin and Bleichroeder have unanimously approved the proposed transaction. The deal is subject to customary closing conditions, including approval by Bleichroeder shareholders and regulatory review. The deal is expected to close in early 2026. Joel L. Rubinstein of White & Case LLP and Ellenoff Grossman & Schole LLP act as legal advisor, Cantor Fitzgerald & Co. and Cohen & Company act as financial advisor for Bleichroeder Acquisition Corp. I. Stephen W. Ranere of Latham & Watkins LLP as legal advisor,TD Securities (USA) LLC act as financial advisor for Merlin Labs, Inc. Greenberg Traurig is serving as legal advisor to TD Cowen. 
